Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?
- 30 September 2007
- journal article
- Published by Elsevier BV in Physiology & Behavior
- Vol. 92 (1-2), 226-231
- https://doi.org/10.1016/j.physbeh.2007.05.016
Abstract
Dysregulation of the monoaminergic systems is likely a sufficient but not a necessary cause of depression. A wealth of data indicates that neuropeptides, e.g., NPY, CRH, somatostatin, tachykinins and CGRP play a role in affective disorders and alcohol use/abuse. This paper focuses on NPY in etiology and pathophysiology of depression. Decreased peptide and mRNA NPY were found in hippocampus of both the genetic, e.g., the FSL strain, and environmental rat models of depression, e.g., chronic mild stress and early life maternal separation paradigms. Rat models of alcoholism also show altered NPY. Furthermore, NPY is also reduced in CSF of depressed patients. Antidepressive treatments tested so far (lithium, topiramate, SSRIs, ECT and ECS, wheel running) increase NPY selectively in rat hippocampus and in human CSF. Moreover, NPY given icv to rat has antidepressive effects which are antagonized by NPY-Y1 blockers. The data support our hypothesis that the NPY system dysregulation constitutes one of the biological underpinnings of depression and that one common mechanism of action of antidepressive treatment modalities may be effects on NPY and its receptors. In a novel paradigm, early life maternal separation was superimposed on “depressed” FSL and control rats and behavioral and brain neurochemistry changes observed in adulthood. The consequences were more deleterious in genetically vulnerable FSL. Early antidepressive treatment modulated the adult sequelae. Consequently, if these data are confirmed, the ethical and medical question that will be asked is whether it is permissible and advisable to consider prophylactically treating persons at risk.Keywords
This publication has 37 references indexed in Scilit:
- Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006
- Running has Differential Effects on NPY, Opiates, and Cell Proliferation in an Animal Model of Depression and ControlsNeuropsychopharmacology, 2005
- The antidepressant effect of running is associated with increased hippocampal cell proliferationInternational Journal of Neuropsychopharmacology, 2005
- BDNF in schizophrenia, depression and corresponding animal modelsMolecular Psychiatry, 2005
- Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depressionInternational Journal of Neuropsychopharmacology, 2003
- Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line ‘Depressed’ Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing EffectsNeuropsychopharmacology, 2003
- Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene related peptide in adult ratsNeuropharmacology, 2002
- Dopamine receptor antagonists prevent the d‐amphetamine‐induced increase in calcitonin gene‐related peptide levels in ventral striatumJournal of Neuroscience Research, 2001
- Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depressionNeuroscience Letters, 1999
- Neuropeptide Y Levels in Ethanol‐Naive Alcohol‐Preferring and Nonpreferring Rats and in Wistar Rats after Ethanol ExposureAlcohol: Clinical and Experimental Research, 1998